Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Diabetes Prevention Programming for Women With a History of Gestational Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03971838
Recruitment Status : Recruiting
First Posted : June 3, 2019
Last Update Posted : August 7, 2019
Sponsor:
Information provided by (Responsible Party):
Tamara S. Hannon, Indiana University

Brief Summary:
The purpose of this study is to offer women with a history of gestational diabetes access to diabetes prevention programming; their children 10 and older can participate.

Condition or disease Intervention/treatment Phase
Diabetes Mellitus, Type 2 Behavioral: Positive Outcomes for Women Not Applicable

Detailed Description:

The purpose of this study is to offer women with a history of gestational diabetes access to diabetes prevention programming; their children 10 and older can participate. There are two potential types of participants:

  1. Women and their children 10+ can consent to participate in the diabetes prevention programming offered through Dr. Hannon's center (called Encourage). Researchers will collect data at three time points, baseline, 4-6 months, and 12 months.
  2. Instead of participating in Encourage, women may participate in other diabetes prevention programming/weight management programming offered by other entities. Researchers will consent these women into the study to complete 3 data collection points, baseline, 4-6 months, and 12 months. Additionally, researchers will consent women to obtain data from their chosen program. For instance, if a woman chooses to do a Diabetes Prevention Program through the YMCA, researchers will ask women to self report their weekly attendance and weight.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Diabetes Prevention Programming for Women With a History of Gestational Diabetes
Actual Study Start Date : June 1, 2019
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2022

Resource links provided by the National Library of Medicine



Intervention Details:
  • Behavioral: Positive Outcomes for Women

    Women and their children 10+ can consent to participate in the diabetes prevention programming offered through the research center. We will collect data at three time points, baseline, 4-6 months, and 12 months.

    2. Instead of participating in Encourage, women may participate in other diabetes prevention programming/weight management programming offered by other entities. Researchers will consent these women into the study to complete 3 data collection points, baseline, 4-6 months, and 12 months. Additionally, researchers will consent women to obtain data from their chosen program. For instance, if a woman chooses to do a Diabetes Prevention Program through the YMCA, researchers will ask women to self report their weekly attendance and weight.



Primary Outcome Measures :
  1. Enrollment and participation rates in a diabetes prevention intervention [ Time Frame: 12 months ]
    Enrollment and participation rates in a diabetes prevention intervention


Secondary Outcome Measures :
  1. HbA1c [ Time Frame: 12 months ]
    HbA1c

  2. BMI [ Time Frame: 12 months ]
    Height and weight combined to report as BMI



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • History of gestational diabetes in a previous pregnancy
  • Age 18+

Exclusion Criteria:

·Currently pregnant


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03971838


Contacts
Layout table for location contacts
Contact: Tamara Hannon, MD 3172785606 tshannon@iu.edu
Contact: Lisa Smith, MS 3172789615 smithlg@iupui.edu

Locations
Layout table for location information
United States, Indiana
Riley Hospital for Children Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Lisa Smith, MS    317-278-9615    smithlg@iupui.edu   
Contact: Tamara Hannon, MD    3172785606    tshannon@iu.edu   
Sponsors and Collaborators
Indiana University

Layout table for additonal information
Responsible Party: Tamara S. Hannon, Professor, Indiana University
ClinicalTrials.gov Identifier: NCT03971838     History of Changes
Other Study ID Numbers: 1812789354
First Posted: June 3, 2019    Key Record Dates
Last Update Posted: August 7, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes, Gestational
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications